Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M. Sperger, Joshua M. Lang, Lindsay N. Strotman et al.|Clinical Cancer Research|2016Cited by 70
High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1Jennifer L. Schehr, Joshua M. Lang, Zachery D. Schultz et al.|PLoS ONE|2016Cited by 63
Versatile exclusion-based sample preparation platform for integrated rare cell isolation and analyte extractionHannah M. Pezzi, David J. Beebe, David J. Guckenberger et al.|Lab on a Chip|2018Cited by 25
Interrogating Bronchoalveolar Lavage Samples via Exclusion-Based Analyte ExtractionJacob Tokar, David J. Beebe, Jay W. Warrick et al.|SLAS TECHNOLOGY|2017Cited by 3
Supplementary Methods, Supplementary Figures S1, S2, Supplementary Tables S1-S3 from Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M. Sperger, Joshua M. Lang, Lindsay N. Strotman et al.|Unknown|2023Cited by 0